Journal of Business Ethics 132 (3):505-524 (2015)

Abstract
Developing and applying a framework for understanding the complexities of economic and legal considerations in two recent Supreme Court rulings was the focus of this research. Of especial concern was the protection of intellectual property in the pharmaceutical industry. Two cases from 2013 were selected: FTC v. Activis and Association for Molecular Pathology v. Myriad Genetics, Inc.. Part of the rationale for the selection was the importance of the Supreme Court rulings and the importance of the pharmaceutical sector. A qualitative content analysis of the Court’s reported decision in each case was analyzed. Since ethical considerations may or may not be consistent with efficiency considerations of plaintiffs, defendants, or the courts, both efficiency and ethical arguments were included. Equally important to the understanding of the economic and ethical issues in the two above- mentioned cases was the development of a rationale for including and excluding a variety of ethical theories, ultimately influenced by Markkula Center For Applied Ethics Of Santa Clara University and Schumann :93–111, 2001). The refinement and use of a levels analysis approach portrays societal, organizational, and individual impacts, and allows for deeper understanding of litigated cases, irrespective of the country in which the litigation takes place :385–393, 2004; Foss et al., J Manag Stud 47:455–482, 2010). A rationale for this framework is the societal and organizational impacts on the myriad of stakeholders in the pharmaceutical sector. We suggest that this framework can be applied to other industries and other complex conflicts among stakeholders as well.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
ISBN(s)
DOI 10.1007/s10551-014-2365-7
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 65,714
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

Political Liberalism.J. Rawls - 1995 - Tijdschrift Voor Filosofie 57 (3):596-598.
Justifying Intellectual Property.Edwin C. Hettinger - 1989 - Philosophy and Public Affairs 18 (1):31-52.

View all 44 references / Add more references

Citations of this work BETA

Add more citations

Similar books and articles

Intellectual Property and Pharmaceutical Drugs: An Ethical Analysis.of Intellectual Property - 2008 - In Tom L. Beauchamp, Norman E. Bowie & Denis Gordon Arnold (eds.), Ethical Theory and Business. Pearson/Prentice Hall.
Labor as the Basis for Intellectual Property Rights.Bryan Cwik - 2014 - Ethical Theory and Moral Practice 17 (4):681-695.
Are Pharmaceutical Patents Protected by Human Rights?Joseph Millum - 2008 - Journal of Medical Ethics 34 (11):e25-e25.
Can Economics Rank Slavery Against Free Labor in Terms of Efficiency?Lawrence H. White - 2008 - Politics, Philosophy and Economics 7 (3):327-340.
A Pluralistic Account of Intellectual Property.D. B. Resnik - 2003 - Journal of Business Ethics 46 (4):319-335.
Ethical Issues in the Globalization of the Knowledge Economy.Xiaohe Lu - 2001 - Business Ethics, the Environment and Responsibility 10 (2):113–119.

Analytics

Added to PP index
2015-09-03

Total views
16 ( #651,532 of 2,462,617 )

Recent downloads (6 months)
1 ( #449,387 of 2,462,617 )

How can I increase my downloads?

Downloads

My notes